| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.33▲ | 1.32▲ | 1.32▲ | 1.29▲ | 1.41▼ |
| MA10 | 1.33▲ | 1.30▲ | 1.29▲ | 1.30▲ | 1.43▼ |
| MA20 | 1.30▲ | 1.28▲ | 1.28▲ | 1.40▼ | 1.13▲ |
| MA50 | 1.29▲ | 1.27▲ | 1.28▲ | 1.39▼ | 3.81▼ |
| MA100 | 1.28▲ | 1.30▲ | 1.36▼ | 1.15▲ | 11.03▼ |
| MA200 | 1.32▲ | 1.43▼ | 1.51▼ | 2.47▼ | 21.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.007▲ | 0.008▲ | -0.015▼ | 0.310▲ |
| RSI | 62.562▲ | 64.869▲ | 63.292▲ | 46.822▼ | 40.070▼ |
| STOCH | 70.278 | 93.264▲ | 93.525▲ | 34.557 | 41.116 |
| WILL %R | -9.091▲ | -5.556▲ | -5.556▲ | -68.584 | -63.431 |
| CCI | 90.476 | 121.305▲ | 119.537▲ | -7.120 | 1.482 |
|
Wednesday, August 13, 2025 07:54 AM
Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, July 17, 2025 01:30 PM
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.33 | 1.34 | 1.30 | 1.33 | 172,569 |
| 14/08/25 | 1.27 | 1.32 | 1.25 | 1.31 | 196,197 |
| 13/08/25 | 1.25 | 1.30 | 1.21 | 1.28 | 236,682 |
| 12/08/25 | 1.25 | 1.34 | 1.24 | 1.30 | 230,392 |
| 11/08/25 | 1.22 | 1.27 | 1.20 | 1.25 | 163,302 |
| 08/08/25 | 1.28 | 1.3129 | 1.21 | 1.23 | 252,176 |
| 07/08/25 | 1.28 | 1.36 | 1.26 | 1.29 | 192,225 |
| 06/08/25 | 1.33 | 1.365 | 1.27 | 1.28 | 201,892 |
| 05/08/25 | 1.42 | 1.425 | 1.33 | 1.35 | 181,265 |
| 04/08/25 | 1.30 | 1.39 | 1.30 | 1.39 | 176,039 |
|
|
||||
|
|
||||
|
|